Iovance Biotherapeutics (IOVA) Other Accumulated Expenses (2011 - 2024)
Iovance Biotherapeutics' Other Accumulated Expenses was $3.98 million in Q1 2024, down 7.2% from $4.29 million a year earlier and down 39.6% from the prior quarter.
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Other Accumulated Expenses (2011 - 2024) Analysis & Trends
At the end of FY2023, Other Accumulated Expenses at Iovance Biotherapeutics came in at $6.59 million, up 99.6% from FY2022.
- Other Accumulated Expenses shows a five-year compound annual growth rate of 68.2% (FY2018 to FY2023).
- In earlier years, Other Accumulated Expenses was $3.3 million in FY2022 (-12.1%), $3.76 million in FY2021 (+119.4%), $1.71 million in FY2020 (+3.3%) and $1.66 million in FY2019 (+238.9%).
- The Q1 2024 figure marks the lowest quarterly Other Accumulated Expenses since Q4 2022.
- Compared with a year earlier, Other Accumulated Expenses was higher in five of the last eight quarters, with growth averaging 46.3%.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q4 2019 (growth of 238.9%); the worst was Q3 2023 (a decline of 20.8%).
- Per Business Quant data, IOVA's Other Accumulated Expenses in the three quarters before Q1 2024 was $6.59 million (Q4 2023), $4.28 million (Q3 2023) and $4.57 million (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Iovance Biotherapeutics | 6.44 Bn | 5.23 Bn | 55.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 3.98 Mn |
| Dec 31, 2023 | 6.59 Mn |
| Sep 30, 2023 | 4.28 Mn |
| Jun 30, 2023 | 4.57 Mn |
| Mar 31, 2023 | 4.29 Mn |
| Dec 31, 2022 | 3.30 Mn |
| Sep 30, 2022 | 5.41 Mn |
| Jun 30, 2022 | 3.57 Mn |
| Mar 31, 2022 | 2.77 Mn |
| Dec 31, 2021 | 3.76 Mn |
| Sep 30, 2021 | 2.36 Mn |
| Jun 30, 2021 | 1.79 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Dec 31, 2020 | 1.71 Mn |
| Sep 30, 2020 | 2.31 Mn |
| Jun 30, 2020 | 2.09 Mn |
| Mar 31, 2020 | 1.68 Mn |
| Dec 31, 2019 | 1.66 Mn |
| Sep 30, 2019 | 1.52 Mn |
| Jun 30, 2019 | 980,000.00 |
API Access
Iovance Biotherapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IOVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "IOVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IOVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();